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ORIGINAL ARTICLE 
Post-operative nausea and vomiting prophylaxis in adult 
day case surgery: did it justify a local protocol? 
 Muriel Bellizzi, Nicole Grech, Stephen Sciberras
BACKGROUND 
Post-operative nausea and vomiting (PONV) is common following 
surgery and results in complications. The Society of Ambulatory 
Anaesthesia (SAMBA) published internationally established 
guidelines for its prophylaxis. Our aim was to investigate whether 
guidelines were being followed locally. We also assessed incidence of 
PONV, delay in discharge or unplanned admissions in adult surgical 
cases at Day Care Unit. This study was repeated after five years to 
assess the impact of establishing local guidelines in Mater Dei 
Hospital in the same year. 
METHODS 
In this retrospective study, we collected information between August 
and September 2012 and then in 2017. Data regarding vomiting, 
delayed discharge or unplanned admission due to PONV was 
documented. Local guidelines were implemented in 2013. 
Educational measures to raise awareness were carried out, followed 
by a re-audit in 2017. 
RESULTS 
195 patients were eligible in the first study and 173 in the second 
cycle. No statistically significant decrease was found between 
patients having PONV (12.4%and 10% in the re-audit - p<0.01). One 
in ten patients (1%) had an unplanned admission due to PONV during 
the first audit with no admissions in the second study. Number of risk 
factors for PONV did not correlate with anti-emetics given. 
CONCLUSION 
The incidence of PONV in adult day cases at our day care unit justifies 
the use of protocol for better prophylaxis. However, local protocols 
are not being followed. Education and emphasis of local guidelines 
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INTRODUCTION 
Post-operative nausea and vomiting (PONV), 
defined as occurring during the first 24 to 48 
hours after surgery is the most frequent side 
effect after general anaesthesia. It is the least 
desirable outcome following surgery.1 The 
incidence of vomiting and nausea is 
approximately 30% and 50% respectively, and 
this may be as high as 80% in high risk 
patients.2 
PONV is also linked with an increase in health 
care cost. The increased expenditure is due to 
the treatment, delay in discharging of patients 
both in the acute recovery period and at day 
care unit and any unplanned admissions due to 
PONV.3-6 Parra Sanchez et al. established in 
2012 that PONV incurred an extra cost of 75 
US dollars per patient in ambulatory day case 
surgery.7 Another study, also in 2012, by 
Dzwonczyk et al. demonstrated that PONV 
prophylaxis yielded more profits for the 
hospital than treatment of patients who 
returned to hospital following day case 
surgery due to symptoms of PONV.8 The 
concept of PONV incurring extra costs to both 
patients (mainly due to missed wages) and 
hospitals was already being studied in 1994 
when Sanchez et al. published a study about 
these economic considerations in the Journal 
of Clinical Anaesthesia.9 
In 2002, a multidisciplinary international panel 
of experts from the Society of Ambulatory 
Anaesthesia (SAMBA) was set up to review 
medical literature on PONV and to produce 
guidelines for management of PONV. The aim 
of these guidelines was to be reliable, clear 
and above all clinically applicable. The panel 
based their recommendations on the evidence 
regarding the prevention and the minimization 
of PONV. Their primary goals were to identify 
the primary risk factors both in adults and 
children, and to recognize the best approach 
to prevent PONV. A literature review helped to 
identify a list of the strongest risk factors, and 
this list was categorized into three groups; 
patient, anaesthetic and surgical- specific. For 
patients in whom the risk for PONV was low, 
the advice is just to watch; moderate risk 
necessitates 1 or 2 anti-emetics and a high risk 
would require 2 or 3 anti-emetics. Figure 1 
below demonstrates these guidelines.10 
Local practice, at the time of the first cycle, did 
not follow any strategy both in the prevention 
and in the treatment of PONV. It was hence 
felt necessary to offer guiding principles for 
both prophylaxis and treatment of PONV, and 
in May 2014, a Guideline Development Group 
(GDG) produced evidence-based guideline for 
the management of PONV in patients 
undergoing Day Surgery procedures.  
Why were local guidelines developed? 
It is well known that PONV is a particularly 
challenging issue which has a bearing on both 
patient satisfaction and appropriate patient 
discharge. The goal of the recent local 
guidelines is to provide an easy and inclusive 
guide to anaesthetists, foundation doctors, 
anaesthetic and day care unit nurses in order 
to prevent and treat PONV in Adults 
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Figure 1  Society of Ambulatory Anaesthesia Guidelines for PONV Prophylaxis, 2002 
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How does the local guideline differ from the 
existing guidelines issued by the SAMBA? 
The SAMBA 2007 guidelines stratify the risk 
and management according to a rather 
complex flowchart. On the other hand, the 
local guidelines were simplified. These consist 
of two sections, with the first section 
stratifying patients depending on the Apfel 
score.11 The prophylactic treatment is then 
given according to this scoring system, as per 
Figure 2 below. The second part addresses 
treatment of any postoperative nausea and 
vomiting which may occur in stage 1 recovery 
or DCU.  
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It was felt that it would be ideal to re-assess 
the situation before and after the introduction 
of the guideline, hence the purpose of this 
observational study 
The objectives of the first audit done in 2012 
were primarily to assess the local practice 
pattern of PONV prophylaxis and compare this 
with established international guidelines. 
Following the introduction of the local 
protocol for the prevention of PONV, the audit 
was repeated in 2017 to assess such local 
guidelines and their influence on PONV 
incidence. The local incidence of PONV, any 
delay in discharge or unexpected admissions 
secondary to PONV were also assessed. 
METHODS 
A retrospective audit of adult day care surgical 
procedures was performed at the Surgical Day Care 
Unit at Mater Dei Hospital. This was done over a 
period of 6 weeks between August and September 
2012 and again between August and September 2017 
Patients were included if they were older than 18 
years of age, classified as ASA1 or 2, and were 
scheduled for elective surgical procedure under 
general anaesthesia.  
Data collected included demographic information, 
which is depicted in Table 1. Any relevant notes in 
the patients’ files including episodes of nausea or 
vomiting in recovery stay or at day care unit or any 
unplanned admissions were noted. Patients were also 
contacted by telephone 72 hours following surgery 
in order to confirm any post-operative nausea and 
vomiting. Data was collected on Microsoft Excel® 
(Microsoft, US), and analysed using IBM SPSS 
version 24 (IBM, US). 
 
 
Table 1  Demographic data of patients included in this observational study 
  Frequency Percentage 
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Patient assessed for eligibility 
(227 in 2012) (173 in 2017) 
Patients eligible for  
further analysis (205 in 2012) (173 in 2017) 
Excluded  
(22 in 2012)(0 in 2017) 
Contacted patients 72 hours 
 post-operatively (205 in 2012) (173 in 2017) 
Analysis  
(195 in 2012) (170 in 2017) 
Lost to follow-up 
(10 in 2012) (3 in 2017) 



















In total, 400 patients were assessed for 
eligibility, with data from 365 patients being 
analysed as shown in Figure 3 overleaf. 
Demographic data for the two groups is shown 
in Table 1, with most of the patients being 
middle aged, female non-smokers. Most 
patients had risk factors for PONV. The 
incidence of PONV in 2012 was 12.8%. In 2017, 
this incidence was 10%. There was an overall 
use prophylactic anti-emetics in 51.1% of the 
total cohort.  
Table 2 exhibits the number of patients 
receiving anti-emetic prophylaxis. 
Dexamethasone was the commonest drug 
used as prophylaxis, followed by Ondansetron, 
which had only been recently introduced in 
2012. In all, the total number of doses of 
antiemetics given was 193. 
The use of prophylactic drugs for the 
prevention of PONV was compared to the 
number of risk factors, especially for previous 
episodes of PONV. Overall, those patients who 
did have previous PONV received an 
antiemetic in 79.4% of cases, whereas 66.1% of 
cases received an antiemetic even if there was 
no history of PONV. 
Local guidelines based on Apfel score were 
used as the audit standard for the second cycle 
of the audit. 
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Table 2  Anti-Emetic Doses given as prophylaxis 
Anti-Emetic Drug Number of Patients Given Prophylaxis 




Dexamethasone 40 105 
Metoclopramide 5 9 
Prochlorperazine 6 0 
Ondansetron 16 12 
Differences between the two cycles 
As shown previously in Table 1, there were no 
particular differences in the demographic data 
for patients in the two groups. 
The number of patients suffering PONV in the 
first cycle was 25 (12.8%), whereas that in the 
second cycle was 17 (10%). This was not 
statistically different. 
The use of an antiemetic was much more 
common in the second cycle, than in the first: a 
total of 126 doses of an antiemetic were given 
in 105 patients (62%), compared to 67 doses in 
53 patients (27%). Details of the use of 
antiemetics in each group is shown in Table 2. 
In the second cycle, despite the 
recommendations, 58% of patients still 
received an antiemetic, despite having an 
Apfel score of 0 or 1. A small fraction (6%) of 
these patients even received two antiemetics. 
This should be considered as inappropriate 
treatment, as the guidelines do not 
recommend anti-emetic prophylaxis for these 
patients. In total, 225 patients were over-
treated. The total extra cost for said 
overtreatment was calculated at 184.34 euro, 
using procrurement prices for the antiemeitcs 
used.12 
In groups of patients with Apfel score of 2, 
79.1% of patients were given one anti-emetic 
and nobody was given two anti-emetics. 
Patients with an Apfel score of 3 were given 
one anti-emetic agent in 66.7% of cases and 
16.7% received two anti-emetics.  
All the patients with Apfel score of 4 were 
given one anti-emetic. These were supposed 
to receive more than one class of antiemetic, 
so these patients were undertreated.  
In the second cycle, 9 patients were found to 
have no risk factors for PONV. A total of 17 
patients (10%) experienced post-operative 
nausea and 11 patients (6.5%) actually 
vomited.  Of these, 5% were given rescue anti-
emetics in the recovery area (most common 
agent used being ondansetron) and 1% were 
given rescue treatment in day care unit (0.5% 
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Our study shows that the lack of local 
guidelines allowed for a variety of practices 
which were not based on evidence. However, 
the introduction of such local guidelines do not 
significantly improve adherence to established 
international guidelines. 
The overall rate of PONV in our cohort of 
patients was 11%. This compares to other 
studies, such as by Gan et al, which quotes a 
figure of up to 30% in the US.15 
The use of dexamethasone as an antiemetic is 
well-established.16 It is considerably cheaper 
than ondansetron, and it also seems to 
improve analgesia.17 This might have 
contributed to dexamethasone use being so 
prevalent, and to the overuse of this drug even 
if there was no specific indication. 
It is disheartening to see that despite the 
introduction of a local policy, adherence after 
a year was so poor. A lot of patients received 
anti-emetics when not indicated, but a lot of 
patients also received too little when this was 
indicated. However, such an effect is not new. 
19– 21 Kooij et al studied PONV prophylaxis 
being prescribed preoperatively for patients 
with 3 or more risk factors. Only 35% of these 
patients were appropriately prescribed 
prophylaxis. They recommended that 
electronic alerts included in the  preoperative 
system may improve these results.19 Brampton 
et al carried out a yearly audit about incidence 
of PONV in their centre and the best rate of 
adherence to PONV prophylaxis guidelines 
was reported in 2012 when it was 67%.20 In a 
multicenter observational study in 2013, White 
et al showed that maximal drop was obtained 
in PONV rates when more than three anti-
19
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emetics were given to patients, however less 
than 70% adherence to hospital guidelines was 
noted.21   
A number of limitations were identified 
related to this study. Firstly, ophthalmic and 
ENT surgery patients were not included since 
they do not attend day care unit even for day 
case procedures. These operations are 
generally known to carry significant risk of 
PONV. In our study, we did not differentiate 
between early or late PONV. Patient 
satisfaction with anti-emetic prophylaxis was 
not noted. 
Pain scores were not taken into account during 
this study. Pain, especially if severe, can 
influence the perception of nausea and 
vomiting, and can also increase use of 
opiates.22 Patient’s overall satisfaction with 
their experience was also not included.  
Improved awareness and education regarding 
PONV guidelines will help improve adherence. 
In some centres, computer systems are used in 
anaesthesia with automated reminders 
regarding PONV prophylaxis, and this has been 
shown to improve compliance.23 These 
automated reminders may even be customized 
to request a reason for non-adherence to 
guidelines, and this has also improved 
compliance in itself.24 Having guidelines in 
place for specific types of surgery which are 
considered high risk, such as breast and 
gynaecological surgery, may also help to 
improve outcomes.25 Simplifying algorithms 
for PONV prophylaxis and treatment as much 
as possible has also been shown to help26, 
however our local guideline is already quite 
simple at present. 
This study highlighted the fact that locally, 
despite the introduction of new guidelines 
regarding prophylaxis and management of 
post-operative nausea and vomiting, 
adherence is still relatively poor and 
improvement is needed to avoid both over-
treatment with its attendant costs as well as 
under-treatment with resulting morbidity.   
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